Coastland Capital’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-1,306,848
Closed -$11.7M 160
2016
Q3
$11.7M Buy
+1,306,848
New +$9.29M 0.46% 54

Coastland Capital's RPTP Position: Q4 2016 in Review

Coastland Capital sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 1,306,848 shares — an estimated $11.7M sold.

Coastland Capital first reported a position in RPTP in Q3 2016 and held it in 1 quarter. The position peaked at $11.7M in Q3 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • Coastland Capital reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • Coastland Capital sold 1,306,848 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $11.7M.
  • Coastland Capital first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2016 and held it in 1 quarter.
  • Coastland Capital's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $11.7M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Coastland Capital's 13F filing for Q4 2016, filed 14 Feb 2017.